ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,405Medicare Part D Prescriptions Filled, Including Refills

Rank: 208 out of 676

$641K Total Retail Price of All Prescriptions

Rank: 153 out of 676

250 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 250 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

30% of this provider’s 250 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 7,912 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
HYDROCODONE-ACETAMINOPHEN 411 311 S3 1 1
FUROSEMIDE 361 297 2 4
OMEPRAZOLE 319 241 3 2
AMLODIPINE BESYLATE 297 262 4 3
POTASSIUM CHLORIDE 260 209 5 9
SIMVASTATIN 249 205 6 6
MELOXICAM 225 157 7 13
LISINOPRIL 199 176 8 5
AMLODIPINE BESYLATE-BENAZEPRIL 167 130 9 44
CLOPIDOGREL 162 137 10 28
TRAMADOL HCL 158 111 11 19
LEVOTHYROXINE SODIUM 157 152 12 7
NAMENDA 153 125 13 35
ZOLPIDEM TARTRATE 142 105 14 21
PLAVIX 123 95 15 40
RANITIDINE HCL 120 77 16 27
METOCLOPRAMIDE HCL 119 90 17 107
GABAPENTIN 113 79 18 10
POLYETHYLENE GLYCOL 3350 113 95 18 56
SYNTHROID 107 63 20 48
LOVASTATIN 103 72 21 33
METOPROLOL TARTRATE 92 91 22 22
TRAZODONE HCL 91 46 23 36
ATENOLOL 88 58 24 25
LYRICA 86 54 25 57
HYDRALAZINE HCL 84 68 26 77
NEXIUM 82 72 27 23
ACTOS 81 54 28 106
CARVEDILOL 80 72 29 15
COUMADIN 78 70 30 193
METFORMIN HCL 78 58 30 8
IBUPROFEN 77 61 32 102
CRESTOR 76 58 33 29
ACETAMINOPHEN-CODEINE 75 50 S3 34 112
DONEPEZIL HCL 73 73 35 24
ISOSORBIDE MONONITRATE ER 72 60 36 54
DIOVAN 71 34 37 37
HYDROCHLOROTHIAZIDE 70 55 38 12
ESCITALOPRAM OXALATE 68 68 39 73
AZITHROMYCIN 61 52 40 39
CYCLOBENZAPRINE HCL 60 19 R 41 50
CLONIDINE HCL 59 59 42 32
JANUVIA 57 57 43 78
LOSARTAN POTASSIUM 56 41 44 34
SPIRONOLACTONE 56 38 44 62
PRAMIPEXOLE DIHYDROCHLORIDE 56 41 44 204
RISPERIDONE 55 23 47 69
TAMSULOSIN HCL 54 52 48 38
DEXILANT 53 37 49 155
DOXYCYCLINE HYCLATE 52 44 50 82
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 29, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.